Program

All times are in EDT.

• 8:30 am – 9:30 am: Registration

• 8:30 am – 9:30 am: Refreshment

• 9:00 am – 9:10 am: Opening Remarks: Mary Zhao, ASA CT Chapter Vice President

• 9:10 am – 12:00 pm: Scientific Session I
  • 9:10 am – 9:50 am: Scaling Insights in Cancer Care with Machine Learning, Will Shapiro, Flatiron Health;
  • 9:50 am – 10:30 am: Advancing Clinical Development through Real-World Data, AI and Machine Learning, Harry Yang, Fate Therapeutics;
  • 10:30 am – 10:40 am: Break
  • 10:40 am – 11:20 am: Methods and Applications of AI/ML in Drug Discover, Christopher Langmead, Amgen;
  • 11:20 am – 12:00 pm: FDA’s Perspective on the Use of AI/ML in Drug Development, Tala Fakhouri, U.S. FDA;

• 12:00 pm -– 1:00 pm: Lunch

• 1:00 pm – 3:50 pm: Scientific Session II
  • 1:00 pm – 1:40 pm: Multimodal Integration in the Age of Million Cells and Billion Parameters, Himel Mallick, Cornell University;
  • 1:40 pm – 2:20 pm: Mapping the Mind: Modeling Brain Connectivity and Its Link to Behavior, Yize Zhao, Yale University;
  • 2:20 pm – 2:30 pm: Break
  • 2:30 pm – 3:10 pm: iPIPE: Bayesian Supervised Learning under Monotonicity with Applications in mHealth and Cancer Screening, Ken Cheung, Columbia University;
  • 3:10 pm – 3:50 pm: Clinical Drug Developments: Challenges and Data Science Applications, Dacheng Liu, Boehringer Ingelheim;

• 3:50 pm – 4:15 pm: Discussion, Yi Liu, ASA CT Chapter Secretary

• 4:15 pm – 4:30 pm: Closing Remarks: Professor Kun Chen